MedTrace Logo

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

NCT06570057 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-08-26

No results posted yet for this study

Summary

This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.

Conditions

  • Type II Diabetes Mellitus

Interventions

BEHAVIORAL

Participatory, learning and Action (PLA) Based intervention

An PLA based intervention would be carried out to prepare the Diabetes Mellitus type II patients. The intervention would be carried out for a tentative time of 2 to 3 hours to educate the type II diabetes mellitus. The study participants would be evaluated after completion of 18 months of the intervention. A structured, validated and literature-based assessment checklist will be devised to assess the effectiveness and feasibility of the intervention.

Sponsors & Collaborators

  • University of York

    collaborator OTHER

  • Khyber Medical University Peshawar

    collaborator OTHER

  • HealthNet TPO

    collaborator OTHER

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Aga Khan University Hospital, Pakistan

    collaborator OTHER

  • Baqai Institute of Diabetology and Endocrinology

    lead OTHER

Principal Investigators

  • Abdul Basit, Director · Baqai Institute of Diabetes and Endocrinology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-24
Primary Completion
2026-11-30
Completion
2027-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06570057 on ClinicalTrials.gov